EP3054976
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATMENT OF ATHEROSCLEROSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
10.10.2014EP published:
8.7.2020EP application number:
14853023.1
EPO information:
European Patent Register
Max expiry date:
9.10.2034
Title:
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATMENT OF ATHEROSCLEROSIS
Timeline
Today
10.10.2014EP application
8.7.2020EP Publication
Owner
Name:
Vaccinex, Inc.Address:
1895 Mt. Hope Avenue, Rochester, NY 14620, US
Inventor
Name:
ZAUDERER, MauriceAddress:
Pittsford, New York 14534, US
Priority
Number:
201361889421 PDate:
10.10.2013Country:
US
Classification
Categories:
A61K 39/395, A61K 39/00